Nubeqa
Payments companies reported to CMS as associated with Nubeqa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Nubeqa, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Nubeqa
These are the largest totals companies reported as associated with Nubeqa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Zachary Klaassen | Augusta, GA | Surgery | $214,767.56 |
| Vijay Gunuganti | San Antonio, TX | Medical Oncology | $186,199.46 |
| Gordon Brown | Cherry Hill, NJ | Urology | $97,678.54 |
| Scott Sellinger | Tallahassee, FL | Urology | $89,649.73 |
| Elward Crawford | San Diego, CA | Urology | $89,593.25 |
| Bryan Mehlhaff | Springfield, OR | Urology | $78,676.45 |
| Neal Shore | Myrtle Beach, SC | Urology | $77,430.99 |
| Joelle Hamilton | Homewood, AL | Medical Oncology | $76,595.84 |
| Nancy Dawson | Washington, DC | Medical Oncology | $76,405.06 |
| Lawrence Gervasi | Middleburg Heights, OH | Urology | $74,295.49 |
Prescribed Nubeqa?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.